185 related articles for article (PubMed ID: 25008175)
1. Fine mapping and functional studies of risk variants for type 1 diabetes at chromosome 16p13.13.
Tomlinson MJ; Pitsillides A; Pickin R; Mika M; Keene KL; Hou X; Mychaleckyj J; Chen WM; Concannon P; Onengut-Gumuscu S
Diabetes; 2014 Dec; 63(12):4360-8. PubMed ID: 25008175
[TBL] [Abstract][Full Text] [Related]
2. The type 1 diabetes candidate gene Dexi does not affect disease risk in the nonobese diabetic mouse model.
Nieves-Bonilla JM; Kiaf B; Schuster C; Kissler S
Genes Immun; 2020 Jan; 21(1):71-77. PubMed ID: 31435002
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus.
Leikfoss IS; Mero IL; Dahle MK; Lie BA; Harbo HF; Spurkland A; Berge T
Genes Immun; 2013 Jan; 14(1):62-6. PubMed ID: 23151489
[TBL] [Abstract][Full Text] [Related]
4. Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene.
Davison LJ; Wallace C; Cooper JD; Cope NF; Wilson NK; Smyth DJ; Howson JM; Saleh N; Al-Jeffery A; Angus KL; Stevens HE; Nutland S; Duley S; Coulson RM; Walker NM; Burren OS; Rice CM; Cambien F; Zeller T; Munzel T; Lackner K; Blakenberg S; ; Fraser P; Gottgens B; Todd JA; Attwood T; Belz S; Braund P; Cambien F; Cooper J; Crisp-Hihn A; Diemert P; Deloukas P; Foad N; Erdmann J; Goodall AH; Gracey J; Gray E; Williams RG; Heimerl S; Hengstenberg C; Jolley J; Krishnan U; Lloyd-Jones H; Lugauer I; Lundmark P; Maouche S; Moore JS; Muir D; Murray E; Nelson CP; Neudert J; Niblett D; O'Leary K; Ouwehand WH; Pollard H; Rankin A; Rice CM; Sager H; Samani NJ; Sambrook J; Schmitz G; Scholz M; Schroeder L; Schunkert H; Syvannen AC; Tennstedt S; Wallace C
Hum Mol Genet; 2012 Jan; 21(2):322-33. PubMed ID: 21989056
[TBL] [Abstract][Full Text] [Related]
5. Association of type 1 diabetes with two Loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese.
Awata T; Kawasaki E; Tanaka S; Ikegami H; Maruyama T; Shimada A; Nakanishi K; Kobayashi T; Iizuka H; Uga M; Kawabata Y; Kanazawa Y; Kurihara S; Osaki M; Katayama S;
J Clin Endocrinol Metab; 2009 Jan; 94(1):231-5. PubMed ID: 18940880
[TBL] [Abstract][Full Text] [Related]
6. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes.
Hirschfield GM; Xie G; Lu E; Sun Y; Juran BD; Chellappa V; Coltescu C; Mason AL; Milkiewicz P; Myers RP; Odin JA; Luketic VA; Bacon B; Bodenheimer H; Liakina V; Vincent C; Levy C; Pillai S; Lazaridis KN; Amos CI; Siminovitch KA
Genes Immun; 2012 Jun; 13(4):328-35. PubMed ID: 22257840
[TBL] [Abstract][Full Text] [Related]
7. Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
Leikfoss IS; Keshari PK; Gustavsen MW; Bjølgerud A; Brorson IS; Celius EG; Spurkland A; Bos SD; Harbo HF; Berge T
PLoS One; 2015; 10(7):e0132957. PubMed ID: 26203907
[TBL] [Abstract][Full Text] [Related]
8. Clarifying the function of genes at the chromosome 16p13 locus in type 1 diabetes: CLEC16A and DEXI.
Gingerich MA; Sidarala V; Soleimanpour SA
Genes Immun; 2020 Feb; 21(2):79-82. PubMed ID: 31570815
[TBL] [Abstract][Full Text] [Related]
9. Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex.
Zuvich RL; Bush WS; McCauley JL; Beecham AH; De Jager PL; ; Ivinson AJ; Compston A; Hafler DA; Hauser SL; Sawcer SJ; Pericak-Vance MA; Barcellos LF; Mortlock DP; Haines JL
Hum Mol Genet; 2011 Sep; 20(17):3517-24. PubMed ID: 21653641
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency.
Skinningsrud B; Husebye ES; Pearce SH; McDonald DO; Brandal K; Wolff AB; Løvås K; Egeland T; Undlien DE
J Clin Endocrinol Metab; 2008 Sep; 93(9):3310-7. PubMed ID: 18593762
[TBL] [Abstract][Full Text] [Related]
11. Variants in the BACH2 and CLEC16A gene might be associated with susceptibility to insulin-triggered type 1 diabetes.
Onuma H; Kawamura R; Tabara Y; Yamashita M; Ohashi J; Kawasaki E; Imagawa A; Yamada Y; Chujo D; Takahashi K; Suehiro T; Takata Y; Osawa H; Makino H
J Diabetes Investig; 2019 Nov; 10(6):1447-1453. PubMed ID: 30970177
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis.
Kottyan LC; Maddox A; Braxton JR; Stucke EM; Mukkada V; Putnam PE; Abonia JP; Chehade M; Wood RA; Pesek RD; Vickery BP; Furuta GT; Dawson P; Sampson HA; Martin LJ; Kelly JA; Kimberly RP; Sivils K; Gaffney PM; Kaufman K; Harley JB; Rothenberg ME
Genes Immun; 2019 Apr; 20(4):281-292. PubMed ID: 29904099
[TBL] [Abstract][Full Text] [Related]
13. DEXI, a candidate gene for type 1 diabetes, modulates rat and human pancreatic beta cell inflammation via regulation of the type I IFN/STAT signalling pathway.
Dos Santos RS; Marroqui L; Velayos T; Olazagoitia-Garmendia A; Jauregi-Miguel A; Castellanos-Rubio A; Eizirik DL; Castaño L; Santin I
Diabetologia; 2019 Mar; 62(3):459-472. PubMed ID: 30478640
[TBL] [Abstract][Full Text] [Related]
14. More CLEC16A gene variants associated with multiple sclerosis.
Nischwitz S; Cepok S; Kroner A; Wolf C; Knop M; Müller-Sarnowski F; Pfister H; Rieckmann P; Hemmer B; Ising M; Uhr M; Bettecken T; Holsboer F; Müller-Myhsok B; Weber F
Acta Neurol Scand; 2011 Jun; 123(6):400-6. PubMed ID: 20849399
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of CLEC16A region and autoimmune thyroid diseases.
Muhali FS; Cai TT; Zhu JL; Qin Q; Xu J; He ST; Shi XH; Jiang WJ; Xiao L; Li DF; Zhang JA
G3 (Bethesda); 2014 Mar; 4(6):973-7. PubMed ID: 24646814
[TBL] [Abstract][Full Text] [Related]
16. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis.
Skinningsrud B; Lie BA; Husebye ES; Kvien TK; Førre Ø; Flatø B; Stormyr A; Joner G; Njølstad PR; Egeland T; Undlien DE
Ann Rheum Dis; 2010 Aug; 69(8):1471-4. PubMed ID: 19734133
[TBL] [Abstract][Full Text] [Related]
17. The expanding genetic overlap between multiple sclerosis and type I diabetes.
International Multiple Sclerosis Genetics Consortium (IMSGC)
Genes Immun; 2009 Jan; 10(1):11-4. PubMed ID: 18987646
[TBL] [Abstract][Full Text] [Related]
18. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus.
Zouk H; D'Hennezel E; Du X; Ounissi-Benkalha H; Piccirillo CA; Polychronakos C
Clin Exp Immunol; 2014 Mar; 175(3):485-97. PubMed ID: 24237155
[TBL] [Abstract][Full Text] [Related]
19. Intron polymorphism in the KIAA0350 gene is reproducibly associated with susceptibility to type 1 diabetes (T1D) in the Han Chinese population.
Wu X; Zhu X; Wang X; Ma J; Zhu S; Li J; Liu Y
Clin Endocrinol (Oxf); 2009 Jul; 71(1):46-9. PubMed ID: 19178520
[TBL] [Abstract][Full Text] [Related]
20. Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.
Mero IL; Ban M; Lorentzen ÅR; Smestad C; Celius EG; Sæther H; Saeedi H; Viken MK; Skinningsrud B; Undlien DE; Aarseth J; Myhr KM; Granum S; Spurkland A; Sawcer S; Compston A; Lie BA; Harbo HF
Genes Immun; 2011 Apr; 12(3):191-8. PubMed ID: 21179112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
